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Introduction
Target delineation is a crucial and complex task in the radiotherapy process. It requires skill and experience to translate surgical notes, information from diagnostic imaging and pathology reports into a 3D volume in the treatment-planning CT data set. Many studies on inter-physician variability in target delineation for conformal radiotherapy have been presented for adults (1) (2) (3) (4) (5) (6) . They all show that there is a significant variation between individuals delineating target volumes for various tumour sites. However, paediatric/adolescent diagnoses have been sparsely discussed. Coles et al (7) introduced a new study protocol for medulloblastoma to a group of paediatric radiation oncologists at an educational meeting including a practical target outlining session. This exercise discovered ambiguities in the protocol and highlighted inter-clinician variation in target segmentation.
Padovani et al (8) also studied inter-clinician variability in target delineation and its effect on the dose distribution to organs at risk (OARs).
For most paediatric/adolescent tumour sites, treatment study protocols are available.
However, they can be difficult to read and interpret correctly because they can be very comprehensive. The chemotherapy part of the protocol is often very detailed while the radiotherapy is often described in more general terms. Other complicating issues may be interference with local practice or sometimes the intention with the treatment (curative or palliative).
Approximately 100 paediatric/adolescent patients receive radiation therapy yearly in Sweden.
They are mainly treated according to international treatment protocols. Radiotherapy of paediatric and adolescent patients in Sweden is centralised to six university hospitals (Göteborg, Linköping, Lund, Stockholm, Umeå and Uppsala).
As part of the quality assurance work within the "Swedish Workgroup for Paediatric Radiotherapy" (SWPR), and as a base for future improvements on this matter, the group decided to perform a "dummy-run" on structure segmentation and treatment planning. Four cases with different diagnoses were selected among recently treated patients. The dummy run results were subsequently openly discussed within the group during a two-day workshop.
The primary aim of the present investigation was to identify and quantify the differences between the participating centres in the segmentation of target volumes, and secondarily, to evaluate the resulting differences in the dose distributions to target volumes and OARs.
Thirdly, we aimed to identify reasons for any differences found.
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Material and Methods
Five of the six centres participated in this study. The cases investigated were: Wilms' tumour, Hodgkin's disease, rhabdomyosarcoma of the prostate, and chordoma of the skull base. The centres who contributed to selection of these cases were instructed to export the necessary data in Dicom-RT format (CT-images, structures, plan and dose) from their treatment planning system and send it together with any relevant diagnostic information (MR-and CTstudies) and medical records including histopathology reports, to the study coordinator (IK).
Relevant anonymised medical data and planning CT data sets were then made available to the centres on an FTP server were the cases were organised and stored for easy access.
The centres were instructed to introduce the cases in their treatment planning system (TPS), to consider them as "their own" patients and to delineate target volumes based on the data provided and valid study protocols. They were not specifically instructed to delineate GTV (gross target volume), CTV (clinical target volume) or PTV (planning target volume) (9), however, all centres delineated CTV and PTV. They were also asked to delineate OARs and to create treatment plans as they normally would, according to the protocols and their local 
Data analysis
To facilitate the comparison of data from the different TPSs, treatment plans were analysed with the CERR software package (10) . From CERR, data for all volumes, targets as well as OARs, could be retrieved and compared. Dose-volume histograms (DVH) were also extracted.
To quantify the variability in target delineation for the five different centres we used the generalized conformity index, CI gen , as derived by Kouwenhoven et al (11) 
Target and OAR volumes
At each centre, participating radiation oncologists defined target volumes and OARs according to the available diagnostic images and reports, treatment protocols and their own experience and practice. Thus, five sets of target volumes and OARs were prepared for each case. All target volumes were mutually compared, i.e. no "golden standard volume" was set.
Dose distributions
We analysed and compared prescribed doses, V 95% , D 98% (near-minimum dose), D 50% (median dose) and D 2% (near-maximum dose) (11) for PTVs. In addition, the homogeneity index (HI=(D 2% -D 98% )/D 50% ) for PTV, treated volume (V 95% for the body) and irradiated volume (V 50% for the body) were calculated for each treatment plan. The mean dose to the remaining volume at risk (RVR), i.e. the total body volume minus CTV(s) and OARs (12) was also calculated.
Results
Prescribed doses
Prescribed doses complied with the existing protocols for cases 1 and 2. Small variations were found for case 3, while major differences were found for case 4 (chordoma) for which no treatment protocol was available. All centres prescribed 14 
Delineated volumes
A large variation in target segmentation was found for the majority of the cases (Figure 1 ). Case 4 -Chordoma. This case showed the best PTV concordance, despite the lack of a study protocol.
Altogether, a substantial variation in PTV volumes was found for all cases (Figure 2 ). The quotients of the largest to the smallest PTV volumes were 4.6, 2.1, 4.3 and 1.7 for cases 1, 2, 3 and 4, respectively. The calculated conformity indices (CI gen ) are shown in Table 1 for CTV and PTV. 
Treatment planning and dose distributions
The majority of the cases where planned with 3D-CRT technique. IMRT was only used by one centre for case 4. Variations in target coverage were mainly due to variation in target volumes. However, the variation in target volume considerably affected the doses to the OARs, especially those close to the tumour volumes. PTV dose-volume data are given in Table 2 for all cases. Table 3 .
In general the extension, shape and position of the PTV are the main contributors to the variation of dose distributions in the OARs. The inclusion of vertebrae in the volume to treat also affected the dose distributions in the OARs. Vertebrae inclusion had a large impact on the size of the treated and irradiated volumes (see Table 3 ). The SIOP 2001 protocol and the GPOH-HD 2002 interim protocol include information on allowed doses to critical organs (included in Table 3 ). Dose volume histograms for the "remaining volume at risk" (RVR) are shown in Figure 3 .
The variations were mainly due to the size of the PTV volume. 
Discussion
We analysed the inter-physician variability in CTV/PTV delineation and found large variation in segmented volumes and in their concordance. We chose the CI gen to compare the conformity between target volumes. This parameter has been shown by Kuwenhoven et al (11) , and confirmed by Fotina et al (14) , to be easily derived and is directly applicable to comparisons of any number of pair-wise delineations, contrary to the commonly used Dice index (15).
It was unfortunately not possible to study the variability in GTV delineation since these structures were not segmented by all centres. One reason for this might be that the ICRU volume concepts are not specified in the study protocols with the exception of SIOP 2002.
Neither the GPOH-HD 2002 nor the CWS protocols use these volume concepts.
PTV dose coverage was adequate for all cases with only small differences between the centres. Therefore, the variation in HI was small for all cases except for case 4. The IMRT plan for this case was optimized to keep the dose to the brainstem and spinal cord at their tolerance levels at the expense of delivering a lower dose to the adjacent target volume while keeping a higher dose to other parts of the PTV.
The inter-clinician variability in target volume delineation affected doses to the nearby OARs and normal tissues to a large extent as previously shown by Padovani et al (8) . In addition, it had a large effect on the treated volume, the irradiated volume, and the remaining volume at risk. The latter volume is applicable for estimating and comparing risk of late effects, such as carcinogenesis (13) . During the two-day workshop a number of case-specific questions were raised which affect the inter-clinician target variability to a large extent. For case 1 the discussion within the group was whether to include the whole vertebrae in the volume to be treated to a therapeutic dose level or not. Some centres argued that the patient was 15 years old at the time of treatment and almost fully grown. Therefore it would be more beneficial for her to minimize the irradiated volume. There is no age-related information on bone irradiation stated in the protocol. An additional discrepancy for this case was the inclusion of the retroperitoneal space. Since there was a rupture of the tumour it should be included in the target volume. The surgeon should (according to protocol) have placed markers to aid the target delineation which was not done. For case 2 the pictogram from the study centre was not included in the material sent out to the participants. However, this information was in the patient notes that were distributed and might explain part of the target variability in this case. For case 3 one centre chose to include the nodes along the pelvic wall which the others did not. This is probably due to different interpretation of the protocol, which is difficult in this case due to recurrent disease. The large variation in prescribed doses for case 4 was due to different opinions regarding the intent (palliative or curative) with the treatment. Moreover, there was a variation between the centres in dose constraints to the brainstem (54-60 Gy) and spinal cord (46-48Gy), which further added to the variation.
Other general reasons for the variability in target segmentation could have been varying experience of physicians as described by Jeanneret-Sozzi et al. (17) . Although the participating physicians in this group have had a long experience of radiotherapy for adults, adolescents and children, the small number of paediatric/adolescent cases that are presented annually at each centre might actually be one of the limiting factors for gaining broader experience in the field. Moreover, variations in standard procedures established locally, might influence the process of radiotherapy for each individual patient.
Establishing detailed radiotherapy protocols, guidelines and templates for target delineation and treatment planning is of great value (18, 19) . Accordingly, it is important that the radiotherapy guidelines in parallel to the medical treatment recommendations of the established protocols, especially in paediatric oncology, are of such quality that they are interpreted unequivocally even though individual tailoring of the treatments might become necessary. Consequently, it is necessary for the radiotherapy guidelines of the protocols to be as explicit as possible concerning the delineations of the target volumes (GTV, CTV and PTV) and OARs. In addition, guidelines should include up-to-date dose-volume constraints/objectives for OARs, preferably including a priority list. Uniform interpretation of the protocols may influence the probability of cure and reduce long-term side effects of the treatment in children. In a recent publication by Fairchild et al (20) , recommendations are given for the writing of a clinical trial protocol, including radiotherapy. In Sweden, the Scientific Council of the Swedish Radiation Safety Authority has pointed out the need for guidelines for the radiotherapy-specific part of a study protocol (21) .
Moreover, performing dummy runs when introducing new study protocols is an important part of treatment development. This may facilitate identification of subsequent differences in interpretation of treatment guidelines and the clinical and practical impacts of possible and unwanted radiotherapy treatment variations for individual cases before the patients are actually treated. Since the outset of the work presented here was a workshop for the specialists, the results indicate that radiotherapy guidelines can be interpreted differently.
Future work within the group will be to follow-up this study and to see whether more frequent target discussions within the group have had any influence on standardisation of the target delineation.
In conclusion, interactive collaboration between radiotherapy centres is an important step to establish new or revised radiotherapy treatment protocols in children and adolescents and to provide continuous peer-based support in day-to-day practice. For our group this "dummyrun" has resulted in several changes. The most common study protocols or guidelines have been translated into Swedish. More effort is put into discussing the extension of the target volumes and doses to OARs during our regular telemedicine meetings (22) . These meetings may be a quick method for quality control (QC) of the treatment or may be a step towards a more advanced QC system as suggested by Carrie et al (23) . Hopefully this will lead to an improved clinical quality for paediatric and adolescents patients on a multi-institutional level, and it can be a way for future harmonization of the process for children undergoing radiotherapy.
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